Federal court: CBD drugmaker GW Pharmaceuticals didn’t violate extraction patent

A Texas court has dismissed a lawsuit accusing pharmaceutical CBD maker GW Pharmaceuticals of violating another company's patented method of cannabidiol extraction for its epilepsy drug Epidiolex,

Federal court: CBD drugmaker GW Pharmaceuticals didn’t violate extraction patent is a post from: Hemp Industry Daily: Financial, Legal & business news for hemp & CBD entrepreneurs

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    scroll to top